Title : Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib.

Pub. Date : 2019 Mar

PMID : 30797499






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 When disease progressed, ROS1 G2032R mutation-a classical mechanism of crizotinib resistance-was detected in the DNA sample extracted from the patient"s plasma sample. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
3 CONCLUSION: We identified a novel WNK1-ROS1 fusion that was sensitive to crizotinib and developed an ROS1 G2032R mutation when the disease progressed. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
4 CONCLUSION: We identified a novel WNK1-ROS1 fusion that was sensitive to crizotinib and developed an ROS1 G2032R mutation when the disease progressed. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens